Sarepta files Form 3 for CEO, director Michael Severino
SRPT•Form 3 filing for Michael Severino
- Sarepta Therapeutics CEO Michael Severino filed an initial Form 3 as a director and officer on July 28, 2026.
Related News
Graphic Packaging declares quarterly dividend of $0.11 a share
GPK•
US FDA approves first freeze-dried plasma product
TFX•
Fortis declares CAD 0.64 common share dividend for Sept. 1 payment
FTS•
Blink Charging director Dennis Charles Schemm files initial beneficial ownership statement
BLNK•
Treasuries-30-year yields hit 19-year highs amid Fed doubts
TLT•